» Articles » PMID: 30203271

DT-Diaphorase Prevents Aminochrome-Induced Lysosome Dysfunction in SH-SY5Y Cells

Overview
Journal Neurotox Res
Publisher Springer
Specialty Neurology
Date 2018 Sep 12
PMID 30203271
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Aminochrome has been reported to induce lysosomal dysfunction by inhibiting the vacuolar H-type ATPase localized in lysosome membrane. DT-diaphorase has been proposed to prevent aminochrome neurotoxicity but it is unknown whether this enzyme prevents aminochrome-induced lysosomal dysfunction. In the present study, we tested the protective role of DT-diaphorase in lysosomal dysfunction by generating a cell line (SH-SY5YsiNQ7) with a stable expression of a siRNA against DT-diaphorase with only 10% expression of mRNA enzyme. The cells differentiated with retinoic acid and 12-o-tetradecanoylphorbol-13-acetate show a significant increase in the expression of tyrosine hydroxylase, vesicular monoamine transporter-2, and dopamine transporter. The incubation of SH-SY5YsiNQ7 cells with 10 μM aminochrome resulted in a significant decrease of lysosome pH determined by using acridine orange, while aminochrome has no effect on SH-SY5Y cells. These results support the proposed protective role of DT-diaphorase against aminochrome-induced lysosomal dysfunction.

Citing Articles

Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson's Disease.

Huenchuguala S, Segura-Aguilar J Antioxidants (Basel). 2024; 13(9).

PMID: 39334784 PMC: 11428591. DOI: 10.3390/antiox13091125.


Single-neuron neurodegeneration as a degenerative model for Parkinson's disease.

Huenchuguala S, Segura-Aguilar J Neural Regen Res. 2023; 19(3):529-535.

PMID: 37721280 PMC: 10581573. DOI: 10.4103/1673-5374.380878.


A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies.

Segura-Aguilar J, Mannervik B Antioxidants (Basel). 2023; 12(3).

PMID: 36978921 PMC: 10045214. DOI: 10.3390/antiox12030673.


Protective Effects of Flavonoid Rutin Against Aminochrome Neurotoxicity.

De Araujo F, Frota A, de Jesus L, Cuenca-Bermejo L, Ferreira K, Santos C Neurotox Res. 2023; 41(3):224-241.

PMID: 36723781 DOI: 10.1007/s12640-022-00616-1.


Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase.

Segura-Aguilar J, Munoz P, Inzunza J, Varshney M, Nalvarte I, Mannervik B Antioxidants (Basel). 2022; 11(2).

PMID: 35204179 PMC: 8868244. DOI: 10.3390/antiox11020296.


References
1.
Zecca L, Fariello R, Riederer P, Sulzer D, Gatti A, Tampellini D . The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease. FEBS Lett. 2002; 510(3):216-20. DOI: 10.1016/s0014-5793(01)03269-0. View

2.
Arriagada C, Paris I, Sanchez de las Matas M, Martinez-Alvarado P, Cardenas S, Castaneda P . On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation. Neurobiol Dis. 2004; 16(2):468-77. DOI: 10.1016/j.nbd.2004.03.014. View

3.
Zafar K, Siegel D, Ross D . A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition. Mol Pharmacol. 2006; 70(3):1079-86. DOI: 10.1124/mol.106.024703. View

4.
Paris I, Perez-Pastene C, Cardenas S, Iturriaga-Vasquez P, Iturra P, Munoz P . Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line. Neurotox Res. 2010; 18(1):82-92. DOI: 10.1007/s12640-009-9148-4. View

5.
Lozano J, Munoz P, Nore B, LeDoux S, Segura-Aguilar J . Stable expression of short interfering RNA for DT-diaphorase induces neurotoxicity. Chem Res Toxicol. 2010; 23(9):1492-6. DOI: 10.1021/tx100182a. View